Results 161 to 170 of about 68,946 (284)

AMN107, a novel aminopyrimidine inhibitor of p190 Bcr‐Abl activation and of in vitro proliferation of Philadelphia‐positive acute lymphoblastic leukemia cells [PDF]

open access: bronze, 2005
Srđan Verstovšek   +12 more
openalex   +1 more source

Durable responses to imatinib in patients with PDGFRB fusion gene–positive and BCR-ABL–negative chronic myeloproliferative disorders [PDF]

open access: bronze, 2006
Marianna Dávid   +23 more
openalex   +1 more source

Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (BCR::ABL+) Acute Lymphoblastic Leukemia (ALL) [PDF]

open access: gold, 2022
Jeannig Berrou   +14 more
openalex   +1 more source

Patients in Focus: What's Relevant for Chronic Myeloid Leukaemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia?

open access: yesEuropean Medical Journal Hematology, 2017
This symposium was dedicated to discussing BCR-ABL-positive chronic myeloid leukaemia (CML) and Philadelphia-positive acute lymphoblastic leukaemia (Ph+ALL).
Michele Baccarani   +4 more
doaj  

Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors [PDF]

open access: bronze, 2009
Simona Soverini   +19 more
openalex   +1 more source

Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia

open access: yesAutophagy, 2015
Xian Zeng   +8 more
semanticscholar   +1 more source

BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.

open access: green, 1991
Alexander J. Muller   +6 more
openalex   +1 more source

Neue Ansätze des molekularen Targetings bei der Philadelphia-Chromosom-positiven Leukämie [PDF]

open access: yes, 2011
In Philadelphia Chromosome (Ph) positive ALL and CML the fusion between BCR and ABL leads to the BCR/ABL fusion proteins, which induces the leukemic phenotype because of the constitutive activation of multiple signaling pathways down-stream to the ...
Mian, Afsar Ali
core  

Home - About - Disclaimer - Privacy